HEPION PHARMACEUTICALS, INC. Stock Split Ratio
HEPION PHARMACEUTICALS, INC. (HEPA) had Stock Split Ratio of 5.00% as of 2023-05-03, per its 10-K filed 2024-04-16.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2024-04-16
- HEPION PHARMACEUTICALS, INC. stockholders' equity note, stock split, conversion ratio for the quarter ending 2023-03-31 was 50.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month |
|---|---|---|
| 2023-05-03 | 5.00% 10-K · filed 2024-04-16 | |
| 2023-03-31 | 50.00% 10-Q · filed 2023-05-12 | |
| 2019-05-28 | 1.43% 10-Q · filed 2020-06-29 | |
| 2018-05-25 | 12.50% 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |